Literature DB >> 22476898

Cell-based therapy improves function in adolescents and young adults with patellar osteochondritis dissecans.

Bryon J X Teo1, Kizher Buhary, Bee-Choo Tai, James H Hui.   

Abstract

BACKGROUND: Recent advances have been made in using chondrocytes and other cell-based therapy to treat cartilage defects in adults. However, it is unclear whether these advances should be extended to the adolescent and young adult-aged patients. QUESTIONS/PURPOSES: We assessed cell-based surgical therapy for patellar osteochondritis dissecans (OCD) in adolescents and young adults by (1) determining function with the International Knee Documentation Committee (IKDC) subjective and Lysholm-Gillquist scores; and (2) evaluating activity level using the Tegner-Lysholm scale.
METHODS: We retrospectively reviewed 23 patients between 12 and 21 years of age (mean 16.8 years) treated for OCD lesions involving the patella from 2001 to 2008. Twenty patients had autologous chondrocyte implantation and three patients had cultured bone marrow stem cell implantation. There were 19 males and four females. We obtained preoperative CT scans to assess patella subluxation, tilt, and congruence angle to determine choice of treatment. We obtained IKDC subjective knee evaluation scores, Tegner-Lysholm activity levels, and Lysholm-Gillquist knee scores preoperatively and at 6, 12, and 24 months postoperatively.
RESULTS: Mean IKDC score, Tegner-Lysholm outcomes, and Lysholm-Gillquist scale improved from 45, 2.5, and 50, respectively, at surgery to 75, 4, and 70, respectively, at 24-month followup. Complications include periosteal hypertrophy observed in two patients.
CONCLUSION: Cell-based therapy was associated with short-term improvement in function in adolescents and young adults with patellar OCD. LEVEL OF EVIDENCE: Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2013        PMID: 22476898      PMCID: PMC3586029          DOI: 10.1007/s11999-012-2338-z

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  31 in total

Review 1.  Articular cartilage lesions of the knee.

Authors:  B R Mandelbaum; J E Browne; F Fu; L Micheli; J B Mosely; C Erggelet; T Minas; L Peterson
Journal:  Am J Sports Med       Date:  1998 Nov-Dec       Impact factor: 6.202

2.  Osteochondritis dissecans of the patella: arthroscopic fixation with bioabsorbable pins.

Authors:  M J Matava; C D Brown
Journal:  Arthroscopy       Date:  1997-02       Impact factor: 4.772

3.  Autologous chondrocyte implantation versus debridement for treatment of full-thickness chondral defects of the knee: an observational cohort study with 3-year follow-up.

Authors:  Freddie H Fu; David Zurakowski; Jon E Browne; Bert Mandelbaum; Christoph Erggelet; J Bruce Moseley; Allen F Anderson; Lyle J Micheli
Journal:  Am J Sports Med       Date:  2005-08-10       Impact factor: 6.202

4.  In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells.

Authors:  B Johnstone; T M Hering; A I Caplan; V M Goldberg; J U Yoo
Journal:  Exp Cell Res       Date:  1998-01-10       Impact factor: 3.905

5.  Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports.

Authors:  Shigeyuki Wakitani; Tomoki Mitsuoka; Norimasa Nakamura; Yukiyoshi Toritsuka; Yukio Nakamura; Shuji Horibe
Journal:  Cell Transplant       Date:  2004       Impact factor: 4.064

6.  The results of operative treatment of osteochondritis dissecans of the patella.

Authors:  C Schwarz; M E Blazina; D J Sisto; L C Hirsh
Journal:  Am J Sports Med       Date:  1988 Sep-Oct       Impact factor: 6.202

7.  Osteochondritis dissecans of the patella.

Authors:  S S Desai; M R Patel; L J Michelli; J W Silver; R T Lidge
Journal:  J Bone Joint Surg Br       Date:  1987-03

8.  Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage.

Authors:  S Wakitani; T Goto; S J Pineda; R G Young; J M Mansour; A I Caplan; V M Goldberg
Journal:  J Bone Joint Surg Am       Date:  1994-04       Impact factor: 5.284

9.  Osteochondritis dissecans patellae. Is there a genetic predisposition?

Authors:  P J Livesley; G F Milligan
Journal:  Int Orthop       Date:  1992       Impact factor: 3.075

10.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation.

Authors:  M Brittberg; A Lindahl; A Nilsson; C Ohlsson; O Isaksson; L Peterson
Journal:  N Engl J Med       Date:  1994-10-06       Impact factor: 91.245

View more
  14 in total

Review 1.  Biological Therapies in Regenerative Sports Medicine.

Authors:  Isabel Andia; Nicola Maffulli
Journal:  Sports Med       Date:  2017-05       Impact factor: 11.136

2.  Injectable cultured bone marrow derived mesenchymal cells vs chondrocytes in the treatment of chondral defects of the knee - RCT with 6 years follow-up.

Authors:  Asode Ananthram Shetty; Seok Jung Kim; Saseendar Shanmugasundaram; Neha Shetty; David Stelzeneder; Chan Sik Kim
Journal:  J Clin Orthop Trauma       Date:  2022-04-04

3.  Autologous osteochondral mosaicplasty in osteochondritis dissecans of the patella in adolescents.

Authors:  Lamine Chadli; Jérôme Cottalorda; Marion Delpont; Philippe Mazeau; Yann Thouvenin; Djamel Louahem
Journal:  Int Orthop       Date:  2016-04-27       Impact factor: 3.075

4.  Clinical and Radiographic Outcomes After Treatment of Patellar Chondral Defects: A Systematic Review.

Authors:  Charles A Su; Nikunj N Trivedi; Hao-Tinh Le; Lakshmanan Sivasundaram; Travis G Maak; Michael J Salata; James E Voos; Michael Karns
Journal:  Sports Health       Date:  2021-04-22       Impact factor: 3.843

5.  What Do We Currently Know About Patellofemoral Osteochondritis Dissecans?

Authors:  Giovanni Bonaspetti; Giovanni Dib; Flavio Azzola; Alessia Piovani
Journal:  Cartilage       Date:  2022 Jan-Mar       Impact factor: 3.117

6.  Influence of Glucose Concentration on Colony-Forming Efficiency and Biological Performance of Primary Human Tissue-Derived Progenitor Cells.

Authors:  Venkata P Mantripragada; Ryan Kaplevatsky; Wes A Bova; Cynthia Boehm; Nancy A Obuchowski; Ronald J Midura; George F Muschler
Journal:  Cartilage       Date:  2020-02-26       Impact factor: 3.117

7.  Cell therapy in joint disorders.

Authors:  Peter D Counsel; Daniel Bates; Richard Boyd; David A Connell
Journal:  Sports Health       Date:  2015-01       Impact factor: 3.843

Review 8.  Mesenchymal stem cells in the treatment of traumatic articular cartilage defects: a comprehensive review.

Authors:  Troy D Bornes; Adetola B Adesida; Nadr M Jomha
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

9.  Matrix-Associated Autologous Chondrocyte Implantation Is an Effective Treatment at Midterm Follow-up in Adolescents and Young Adults.

Authors:  Arnd Hoburg; Ingo Löer; Konrad Körsmeier; Rainer Siebold; Philipp Niemeyer; Stefan Fickert; Klaus Ruhnau
Journal:  Orthop J Sports Med       Date:  2019-04-25

10.  Short- to Midterm Clinical and Radiological Outcomes After Matrix-Associated Autologous Chondrocyte Implantation for Chondral Defects in Knees.

Authors:  Xuesong Dai; Jinghua Fang; Siheng Wang; Jianyang Luo; Yan Xiong; Miaofeng Zhang; Sunan Zhu; Xinning Yu
Journal:  Orthop J Sports Med       Date:  2021-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.